Impact of Electrolyte Abnormalities on Digoxin Toxicity
Mechanism of Increased Toxicity
- Hypokalemia lowers the competition for the cardiac Na⁺/K⁺‑ATPase pump, allowing digoxin to bind more readily; consequently, patients on digoxin can develop toxicity even when serum digoxin concentrations are within the therapeutic range (0.5–2.0 ng/mL). 1 (observational evidence)
Diagnostic Implications
- In the presence of hypokalemia, a “therapeutic” serum digoxin level does not reliably exclude digoxin toxicity; clinicians must interpret digoxin concentrations together with electrolyte values. 1 (clinical observation)
Additional Electrolyte Considerations
- Concurrent hypomagnesemia can potentiate digoxin toxicity even when both digoxin and potassium levels are normal; a reported case responded to intravenous magnesium replacement, illustrating the need to correct magnesium as well as potassium. 1 (single case report – low‑level evidence)
Clinical Outcomes of Toxicity in Hypokalemia
- Digoxin toxicity under hypokalemic conditions commonly produces enhanced atrial, junctional, or ventricular automaticity with atrioventricular block, and may progress to life‑threatening arrhythmias such as ventricular fibrillation, pulseless electrical activity, or asystole if untreated. [2][3] (clinical series)